Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas
Aznar, Marianne Camille
Lee, Lip W
McPartlin, Andrew J
Slevin, Nicholas J
Thomson, David J
van Herk, Marcel
West, Catharine ML
AffiliationDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractOBJECTIVE: To evaluate dosimetric consequences of inter-fraction setup variation and anatomical changes in patients receiving multifield optimised (MFO) intensity modulated proton therapy for post-operative oropharyngeal (OPC) and oral cavity (OCC) cancers. METHODS: Six patients receiving MFO for post-operative OPC and OCC were evaluated. Plans were robustly optimised to clinical target volumes (CTVs) using 3?mm setup and 3.5% range uncertainty. Weekly online cone beam CT (CBCT) were performed. Planning CT was deformed to the CBCT to create virtual CTs (vCTs) on which the planned dose was recalculated. vCT plan robustness was evaluated using a setup uncertainty of 1.5?mm and range uncertainty of 3.5%. Target coverage, D95%, and hotspots, D0.03cc, were evaluated for each uncertainty along with the vCT-calculated nominal plan. Mean dose to organs at risk (OARs) for the vCT-calculated nominal plan and relative % change in weight from baseline were evaluated. RESULTS: Robustly optimised plans in post-operative OPC and OCC patients are robust against inter-fraction setup variations and range uncertainty. D0.03cc in the vCT-calculated nominal plans were clinically acceptable across all plans. Across all patients D95% in the vCT-calculated nominal treatment plan was at least 100% of the prescribed dose. No patients lost ³10%?weight from baseline. Mean dose to the OARs and max dose to the spinal cord remained within tolerance. CONCLUSION: MFO plans in post-operative OPC and OCC patients are robust to inter-fraction uncertainties in setup and range when evaluated over multiple CT scans without compromising OAR mean dose. ADVANCES IN KNOWLEDGE: This is the first paper to evaluate inter-fraction MFO plan robustness in post-operative head and neck treatment.
CitationHague C, Aznar M, Dong L, Fotouhi-Ghiam A, Lee LW, Li T, et al. Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas. The British journal of radiology. 2019:20190638.
JournalBritish journal of Radiology
- Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
- Authors: Stützer K, Lin A, Kirk M, Lin L
- Issue date: 2017 Nov 1
- Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
- Authors: Cubillos-Mesías M, Troost EGC, Lohaus F, Agolli L, Rehm M, Richter C, Stützer K
- Issue date: 2020 Mar
- Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
- Authors: Kraan AC, van de Water S, Teguh DN, Al-Mamgani A, Madden T, Kooy HM, Heijmen BJ, Hoogeman MS
- Issue date: 2013 Dec 1
- Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.
- Authors: Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR
- Issue date: 2014 Jul 15
- Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
- Authors: Kurz C, Nijhuis R, Reiner M, Ganswindt U, Thieke C, Belka C, Parodi K, Landry G
- Issue date: 2016 Apr 30